PhRMA, BIO Seek Full Fed. Circ. Review Of Suprep Patent Row
Two of the life sciences industry's most powerful lobbying forces on Thursday pushed for the full Federal Circuit to review a recent decision in a patent dispute between Braintree Laboratories Inc....To view the full article, register now.
Already a subscriber? Click here to view full article